Skip to main content

InspireMD, Inc.

Data quality: 100%
NSPR
Nasdaq Manufacturing Measuring & Analyzing Instruments
$1.29
▼ $0.02 (-1.53%)
Mkt Cap: 61.66 M
Price
$1.32
Mkt Cap
61.66 M
Day Range
52-Week Range
Volume
Open —
50D / 200D Avg
50D / 200D Avg

Quick Summary

Key Takeaways

Revenue grew 18.88% annually over 5 years — strong growth
Negative free cash flow of -36.77 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.23%

Growth

Revenue Growth (5Y)
18.88%
Above sector avg (1.82%)
Revenue (1Y)28.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-115.67%
Below sector avg (-53.47%)
ROIC-85.27%
Net Margin-543.33%
Op. Margin-552.56%

Safety

Debt / Equity
N/A
Current Ratio6.51
Interest CoverageN/A

Valuation

PE (TTM)
-1.26
Above sector avg (-1.48)
P/B Ratio0.96
EV/EBITDA0.00
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.3 -1.5
P/B 1.0 1.6
ROE % -115.7 -53.5
Net Margin % -543.3 -41.5
Rev Growth 5Y % 18.9 1.8
D/E 0.3

Analyst Price Target

3 analysts
Strong Buy
Current
$1.29
+287.6%
Target
$5.00
$4.00
$5.00
$6.00
Forecast
Forward P/E -2.13
Forward EPS -$0.61
Est. Revenue 27.18 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.61
-$0.65 – -$0.55
27.18 M 3
FY2026 -$0.73
-$0.76 – -$0.70
13.91 M 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.19 -$0.14 +27.6%
Q32025 -$0.20 -$0.17 +12.8%
Q22025 -$0.26 -$0.26 0.0%
Q12025 -$0.20 -$0.22 -10.0%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 28.11% Revenue Growth (3Y) 20.29%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 18.88% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 8.98 M Net Income (TTM) -48.79 M
ROE -115.67% ROA -87.26%
Gross Margin 29.50% Operating Margin -552.56%
Net Margin -543.33% Free Cash Flow (TTM) -36.77 M
ROIC -85.27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.51
Interest Coverage N/A Asset Turnover 0.16
Working Capital 59.58 M Tangible Book Value 64.11 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.26 Forward P/E N/A
P/B Ratio 0.96 P/S Ratio 6.87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 0.00 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -59.63%
Market Cap 61.66 M Enterprise Value -1.75 M
Per Share
EPS (Diluted TTM) -0.76 Revenue / Share 0.19
FCF / Share -0.79 OCF / Share -0.75
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 18.51% FCF Conversion 75.36%
SBC-Adj. FCF -48.69 M Growth Momentum 9.23

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 8.98 M 7.01 M 6.21 M 5.17 M 4.50 M
Net Income -48.79 M -32.01 M -19.92 M -18.49 M -14.92 M
EPS (Diluted) -0.76 -0.76 -0.82
Gross Profit 2.65 M 1.51 M 1.81 M 1.12 M 754,000.0
Operating Income -49.61 M -33.50 M -21.14 M -18.71 M -14.72 M
EBITDA
R&D Expenses 15.00 M 13.63 M 7.98 M 7.81 M 5.16 M
SG&A Expenses
D&A 476.00 M 280.00 M 232.00 M 188,000.0 161,000.0
Interest Expense
Income Tax 63,000.0 59,000.0 65,000.0 28,000.0 45,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 69.40 M 46.81 M 47.64 M 24.65 M 39.71 M
Total Liabilities 14.20 M 10.72 M 8.14 M 7.26 M 6.18 M
Shareholders' Equity 55.20 M 36.09 M 39.50 M 17.39 M 33.53 M
Total Debt
Cash & Equivalents 8.94 M 18.92 M 9.64 M 4.63 M 12.00 M
Current Assets 61.47 M 40.52 M 44.16 M 21.33 M 37.09 M
Current Liabilities 10.71 M 7.68 M 6.02 M 5.07 M 4.35 M